“Delivery of this report will take 1-3 days after purchase.”
A review of big biotech partnering trends and comprehensive directory of deals and alliances announced during 2014.
Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.
The initial chapters of this report provide an orientation of 2014′s dealmaking and business activities.
Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, stage of development, technology type and therapeutic indication.
Chapter 2 provides a review of the leading deals during 2014. Deals are listed by headline value, signed by bigbiotech, and most active bigbiotech. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
Chapter 3 provides a comprehensive listing of the top 50 big biotech companies with a brief summary followed by a comprehensive listing of 2014 deals, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Chapter 4 provides a comprehensive directory of all partnering deals announced during 2014.
The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), therapy area and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
The report series also includes numerous tables and figures that illustrate the trends and activities in bigpharma partnering and dealmaking during 2014.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products during 2014.
“Delivery of this report will take 1-3 days after purchase.”Purchase a copy of the report at http://bit.ly/1GBLwKk
Big Biotech Deals and Alliances of 2014 provides the reader with the following key benefits:
In-depth understanding of big biotech industry dealmaking trends during 2014
Comprehensive access to all big biotech deals entered into by the world’s biopharma companies during 2014
Detailed access to actual partnership deals and contracts entered into by the leading fifty big biotech companies
Understand the key deal terms companies have agreed in previous deals
Full listing of big biotech deals by company A-Z, deal type, technology and therapy focus
Identify leading big biotech deals by value during 2014
Identify the most active big biotech industry dealmakers during 2014
Undertake due diligence to assess suitability of your proposed deal terms for partner companies
Big Biotech Deals and Alliances of 2014is intended to provide the reader with an in-depth understanding and access to parthering and M&A trends and structure of deals entered into by leading companies worldwide.
Big Biotech Deals and Alliances of 2014 includes:
Trends in dealmaking in the bigbiotech industry during 2014
Analysis of partnering and M&A deal structure
Comprehensive directory of partnering and M&A deals in 2014
Links to online access to all deals and alliances
The leading partnering and M&A deals by value in 2014
Most active partnering and M&A dealmakers during 2014
In Big Biotech Deals and Alliances of 2014 series the partnering and M&A deals are listed by:
Stage of development at signing
Deal component type
Each deal title links via Weblink to an online version of the deal record at Current Agreements and where available, the contract document, providing easy access to each contract document on demand.
“Delivery of this report will take 1-3 days after purchase.”For more Information on the report, inquire at http://bit.ly/19aBtAt